Platelet activating factor revisited
Annual Report October 1996 to September 1997
Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor
Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist
Effects of airway calibre on lung delivery of nebulised salbutamol
Respiratory effects of air pollution in chronic obstructive pulmonary disease
Relationship of serum elastin peptide level to single breath transfer factor for carbon monoxide in French coal miners
Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension
Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis
Tuberculosis in England and Wales in 1993
Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome
Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air
Lymphocyte dynamics
Health effects of passive smoking
Recurrent post-partum pulmonary eosinophilia
Pericardial effusion associated with asbestos exposure
Treatment of pleural empyema
Treatment of pleural empyema
Montelukast (MK-0476)
Montelukast (MK-0476)
Pediatric and Adolescent Medicine. Volume 7